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Neuronal development requires highly coordinated regulation of the cytoskeleton within the developing axon. This dynamic regulation manifests itself in axonal branching, turning and pathfinding, presynaptic differentiation, and growth cone collapse and extension. Semaphorin 3A (Sema3A), a secreted guidance cue that primarily functions to repel axons from inappropriate targets, induces cytoskeletal rearrangements that result in growth cone collapse 1 . These effects require intra-axonal messenger RNA translation. Here we show that transcripts for RhoA, a small guanosine triphosphatase (GTPase) that regulates the actin cytoskeleton, are localized to developing axons and growth cones, and this localization is mediated by an axonal targeting element located in the RhoA 3 0 untranslated region (UTR). Sema3A induces intra-axonal translation of RhoA mRNA, and this local translation of RhoA is necessary and sufficient for Sema3A-mediated growth cone collapse. These studies indicate that local RhoA translation regulates the neuronal cytoskeleton and identify a new mechanism for the regulation of RhoA signalling.
Studies using Xenopus retinal axons demonstrated that cytoskeletal regulation of the growth cone by Sema3A requires intra-axonal, or 'local', mRNA translation 2 . Sema3A treatment results in increased protein synthesis in growth cones as shown by metabolic labelling experiments and by phosphorylation of elongation factor 4E-BP1 (ref. 2) . These effects occur within minutes of Sema3A application 2 . Furthermore, Sema3A-mediated growth cone collapse is blocked by ribosomal inhibitors. The mRNA translation that is required for Sema3A-mediated growth cone collapse occurs in the axon, because both Sema3A-induced collapse and inhibition of this collapse by ribosomal inhibitors is preserved in axons that are severed from their cell bodies 2 . To determine whether intra-axonal mRNA translation is required for Sema3A signalling in mammalian neurons, we examined Sema3A-mediated growth cone collapse in embryonic rat dorsal root ganglia (DRG) explant cultures [3] [4] [5] . To eliminate the possibility that the effects of Sema3A were mediated through somatic translation, axons were severed from their cell bodies 2 (see Supplementary  Fig. 1a) . Treatment of severed axons with Sema3A for 60 min resulted in an increase in collapsed growth cones from 17^1.3% to 75^2.8% (see Supplementary Fig. 1b, c, g ). This effect was blocked by pre-treatment of axons with either cycloheximide or anisomycin (see Supplementary Fig. 1 ), both of which are ribosomal inhibitors. Pre-treatment of these cultures with rapamycin, an inhibitor of capdependent translation 6 , also blocked Sema3A-mediated growth cone collapse. Together, these data indicate that the requirement for mRNA translation in mediating the cytoskeletal effects of Sema3A is a conserved feature among vertebrates.
Cytoskeletal alterations in axons are thought to involve members of the Rho family of small GTPases, with roles for Cdc42 and Rac1 in regulating filopodia and lamellipodia formation in growth cones, and RhoA in triggering growth cone collapse and neurite retraction 1 . In DRG neurons, growth cone collapse in response to Sema3A requires the RhoA effector ROCK 7 (see Supplementary Fig. 1g ), implying a role for RhoA activation in Sema3A signalling. Thus, local translation of RhoA or its effectors may contribute to Sema3A-mediated collapse. To identify axonal mRNAs that mediate the effects of Sema3A, we prepared DRG explant cultures and screened axons with a panel of probes using in situ hybridization. Transcripts for RhoA, as well as b-actin (an mRNA previously shown to be localized to the axon 8 ), were present in axons at similar levels by fluorescent in situ hybridization ( Fig. 1a-d ; see also Supplementary Fig. 2a, b) . RhoA mRNA localization was specific because transcripts for ROCK ( Fig. 1e, f ; see also Supplementary Fig. 2e , f), mDIA (another RhoA effector; see Supplementary Fig. 2g, h ), as well as other Rho family GTPases ( Fig. 1g ; see also Supplementary Fig. 2i-l) were not detectable in axons. We next examined RhoA mRNA localization in other types of developing neurons. In situ hybridization experiments with embryonic day (E)18 rat hippocampal neurons and postnatal mouse basal pontine explant neurons also showed axonal localization of RhoA transcripts (see Supplementary Fig. 2m-p) . To further confirm these findings, we performed polymerase chain reaction with reverse transcription (RT-PCR) on RNA obtained from mechanically-isolated DRG axons prepared in modified Boyden chambers (see Supplementary Fig. 3a-c) . RT-PCR of axonal RNA showed the presence of RhoA and b-actin transcripts, but not transcripts for ROCK1 or Rac1 (Fig. 1i) . The glial-specific transcript, glial fibrillary acidic protein (GFAP), and the neuronal somarestricted transcript g-actin 9 , were also absent, confirming the purity of the axonal preparations (see Supplementary Fig. 3d ). These data suggest that the axonal localization of RhoA mRNA is a general feature of developing axons.
In situ hybridization revealed that RhoA transcripts were localized in axons in punctate structures ( Fig. 1c ; see also Supplementary Fig.  2a ). This localization may reflect the incorporation of RhoA mRNA in 'RNA granules' (mobile macromolecular complexes of ribosomes, fragile X-mental retardation protein (FMRP) and mRNA 10 ) that may function to transport mRNA or as sites of translation in neurites 11 . Indeed, staufen, a marker for RNA granules 12, 13 , partially colocalized with RhoA-transcript-containing puncta (see Supplementary Fig. 2q ). We examined RhoA transcript localization in growth cones using actin immunofluorescence to define cellular borders (Fig. 1j) . RhoA mRNA was found in the growth cone periphery indicating that RhoA mRNA may have a role in the regulation of the growth cone cytoskeleton.
Targeting elements in the 3 0 UTR of b-actin mRNA have been implicated in the localization of b-actin transcripts to axons 14 . We did not detect these elements in the RhoA 3 0 UTR. (Fig. 2a) . In situ hybridization with an EGFP-specific probe revealed that only EGFP 3 0 b-actin or EGFP 3 0 RhoA were localized to axons and growth cones ( Fig. 2b-g ; see also Supplementary  Fig. 4a ). The absence of EGFP 3 0 CSE in axons suggests that the observed axonal localization of the EGFP 3 0 b-actin and EGFP 3 0 RhoA is not a consequence of passive diffusion or non-specific transport from the soma. In situ hybridization of infected cell bodies revealed that each EGFP transcript was expressed in the soma (see Supplementary  Fig. 4b ), indicating that the absence of EGFP 3 0 CSE in axons is not an effect of impaired transcript synthesis or stability. These studies indicate that the RhoA 3 0 UTR is sufficient to target heterologous transcripts to axons and growth cones.
The enrichment of RhoA mRNA in axons and growth cones suggests that its local translation might regulate the actin cytoskeleton. The findings that polyadenylated mRNA and large numbers of polyribosomes are present in developing vertebrate axons and growth cones 8, 9, 16 , as well as evidence that axons and axonal preparations have the capacity to synthesize proteins [17] [18] [19] , suggests that axonal translation has a functional role in neuronal development. To determine whether RhoA translation is induced in response to Sema3A, we monitored RhoA levels after Sema3A treatment. Total RhoA levels were determined by summing RhoA immunofluorescence in Z-stack images (collected in 1-mm steps) and normalizing to the volume of the growth cone, using GAP-43 immunofluorescence to define the cellular borders. DRG explants were cultured in medium containing 125 ng ml 21 nerve growth factor (NGF) (rather than 75 ng ml 21 ) to slow the rate of growth cone collapse 7 an additional 2 h, thus allowing images of not yet collapsed growth cones to be taken after 1 h (see Supplementary Fig. 5a, b) . In severed axons, Sema3A treatment resulted in a 2.3^0.2-fold increase in RhoA immunofluorescence ( Fig. 3a-f ). This increase was blocked by pre-treatment with either anisomycin or rapamycin, indicating that protein translation is required for Sema3A-induced increases in RhoA immunofluorescence. This increase was specific to RhoA, as total GAP-43 immunofluorescence levels were unchanged in response to Sema3A treatment (Fig. 3g) .
To monitor the spatial distribution of protein synthesis, we used myr-dEGFP (a destabilized EGFP containing an amino-terminal myristoylation consensus sequence that limits the diffusion of the fluorescent protein from the site of translation 20 ). The myr-dEGFP reporter has a half-life of one hour, thus fluorescent signals represent newly synthesized protein. Infection of DRG explants with a Sindbis viral construct comprising myr-dEGFP and the RhoA 3 0 UTR (Fig. 4a ) resulted in the appearance of fluorescent puncta distributed throughout axons. Treatment with Sema3A for 60 min resulted in the increased intensity of pre-existing puncta as well as the appearance of new puncta in infected axons (Fig. 4b-d) . New or increased fluorescence of pre-existing myr-dEGFP puncta were infrequent in the absence of Sema3A treatment (see Supplementary Fig. 6a, b) . To test the role of protein translation in Sema3A-mediated increases in reporter expression, we pre-treated axons with anisomycin 30 min before the addition of Sema3A. Anisomycin pre-treatment resulted in a complete loss of Sema3A-mediated increase of myr-dEGFP throughout the axon (see Supplementary Fig. 6c, d ). The absence of fluorescence in anisomycin-treated axons after 1 h of Sema3A treatment reflects the lability of myr-dEGFP and indicates that signals at this time point must derive from newly synthesized protein.
Thus, the increase in myr-dEGFP levels on Sema3A treatment is due to increased translation. To assess the effects of Sema3A more comprehensively, 580 puncta were analysed from both the Sema3A-treated and the vehicle-treated axons; we then plotted the fluorescence signal at 0 min and 60 min (Fig. 4d) . Analysis showed distinct populations of puncta after 60 min of Sema3A treatment, comprising both newly-formed puncta and puncta that displayed increased intensity after Sema3A treatment. Most puncta from vehicle-treated axons displayed minimal changes in fluorescence intensity over the 60 min period. The punctate localization may reflect translation at the sites of RNA granules. Furthermore, these experiments indicate that the RNA elements that direct Sema3A-induced translation are located in the 3 0 UTR. The 3 0 UTR of RhoA contains several elements implicated in translational regulation, including several binding sites for microRNAs 21 , and a binding site for FMRP, an RNA-binding protein that regulates translation 22 (see Supplementary Fig. 7) .
We next examined the role of RhoA in Sema3A-mediated growth cone collapse. To assess the role of RhoA in Sema3A-mediated collapse, we examined the effects of Clostridium botulinum C3 exoenzyme, an ADP-ribosyltransferase that inactivates RhoA 23 . Treatment of DRG explant cultures with C3 exoenzyme significantly reduced Sema3A-induced collapse (see Supplementary Fig. 8) , indicating a requirement for RhoA in the cytoskeletal remodelling effects of Sema3A.
We examined the requirement for axonal RhoA mRNA in Sema3A-mediated growth cone collapse. Treatment of cultured, dissociated DRG neurons with small interfering RNA (siRNA) directed against the 5 0 UTR of RhoA mRNA essentially abolished RhoA mRNA in axons (Fig. 5a-d) . In these neurons, we replaced endogenous RhoA transcripts with heterologous RhoA mRNAs that exhibit selective localizations. Transcripts that contain the RhoA 3 0 UTR exhibit axonal localization, whereas transcripts that contain the viral 3 0 CSE are restricted to the soma (Fig. 2) . These viralencoded mRNAs lack the RhoA 5 0 UTR, rendering them resistant to the siRNA. Thus, we infected siRNA-treated neurons with Sindbis pseudovirus expressing EGFP-RhoA transcripts containing either Fluorescence images are shown with inverted contrast to facilitate visualization. Newly formed puncta and puncta with increased signal intensity are seen following Sema3A treatment (bottom panel). Inset, a region of the axon in the top panel is magnified to show changes in puncta number and intensity. Scale bar, 10 mm. c, A line scan performed at 0 min (green trace) and 60 min (orange trace) in the region demarcated by arrows. Newly formed puncta (asterisks) and puncta with increased signal intensity (triangles) are seen after Sema3A treatment. d, Scatter plot of puncta intensities at 0 and 60 min. 580 puncta from experiments monitoring Sema3A-treated (red circles) and vehicle-treated (blue circles) axons were plotted. The majority of points from Sema3A-treated axons remained above the diagonal, indicating newly formed puncta or pre-existing puncta that increased in intensity on Sema3A treatment. Most points from vehicletreated axons remained along the diagonal, indicating that puncta were largely unaffected by vehicle treatment. The background levels in these images averaged approximately 185. the viral 3 0 CSE (EGFP-RhoA 3'CSE ) or the RhoA 3 0 UTR (EGFPRhoA 3'RhoA ). In DRG neurons, siRNA directed against the 5 0 UTR of RhoA markedly reduced Sema3A-mediated growth cone collapse (Fig. 5e) . Infection of these neurons with Sindbis pseudovirus that express EGFP-RhoA 3'CSE failed to restore Sema3A-mediated collapse. Infection with Sindbis pseudovirus that express EGFPRhoA 3'RhoA restored Sema3A-mediated growth cone collapse (Fig. 5e) .
We next examined the sufficiency of RhoA translation in Sema3A-mediated growth cone collapse. Rapamycin, which blocks Sema3A-mediated growth cone collapse, blocks cap-dependent translation. However, rapamycin does not affect cap-independent translation, such as translation initiated at an internal ribosome entry site (IRES) 24 . Thus, we generated Sindbis viral constructs that expressed RhoA in axons via an encephalomyocarditis virus IRES (see Supplementary Fig. 9 ). We monitored growth cone collapse in severed axons from DRG explant cultures infected with either IRES-EGFP or IRES-EGFP-RhoA (Fig. 5f ). Sema3A-mediated growth cone collapse in neurons infected with IRES-EGFP (Fig. 5f ) was similar to that observed in uninfected neurons (see Supplementary Fig. 1g ), and was blocked by rapamycin. We next monitored growth cone collapse in DRG neurons infected with IRES-EGFP-RhoA, that permits EGFPRhoA translation in the presence of rapamycin. We found that rapamycin treatment failed to block Sema3A-mediated growth cone collapse in neurons that express IRES-EGFP-RhoA (Fig. 5f ), indicating that expression of EGFP-RhoA is sufficient to restore growth cone collapse in the presence of rapamycin. Additionally, in neurons that express IRES-EGFP-RhoA but are not treated with Sema3A, baseline levels of growth cone collapse are not significantly different from IRES-EGFP-infected neurons, indicating that EGFPRhoA expression alone is not sufficient for collapse. Sema3A signalling probably involves both translation of RhoA and activation of the newly synthesized protein, perhaps by a Sema3A-regulated guanine nucleotide-exchange factor (GEF). The ability of EGFP-RhoA translation alone to overcome rapamycin blockade of Sema3A suggests that translation of RhoA is required for Sema3A-mediated collapse.
In summary, we have found that RhoA mRNA is enriched in developing axons, and Sema3A-regulated local translation of this transcript mediates cytoskeletal rearrangements in growth cones. Thus, regulation of mRNA translation is an effector pathway of Sema3A, probably through its receptor plexin-A 25 . Given the prominent axonal localization of RhoA mRNA in diverse neuronal types, regulated local RhoA translation is likely to be a widespread mechanism involved in many aspects of neuronal morphogenesis. Local translation permits epistatic regulation of RhoA signalling (distinct from regulation achieved by canonical GEF pathways) by restricting activation of RhoA and its downstream effectors to sites of RhoA translation. GEFs for Rho family GTPases have been identified that mediate cytoskeletal remodelling in axons but do not display high selectivity for specific Rho family members 26 . Activation of these GEFs may result in different outcomes that depend on whether RhoA translation pathways have been activated.
METHODS
Embryonic day (E)15-16 dissociated DRG neurons 27 and explants were plated on glass pre-coated with 33 mg ml 21 poly-D-lysine and 1 mg ml 21 fibronectin. DRGs were cultured in B27/F-12/MEM (Invitrogen) supplemented with 75 ng ml Cycloheximide, anisomycin, rapamycin or C. botulinum C3 exoenzyme was bath-applied 30 min before the application of 450 ng ml 21 Sema3A (R&D) or vehicle (0.1% BSA in PBS) for 60 min in collapse assays. This concentration of Sema3A was empirically determined to cause the maximal degree of collapse within 60 min. Only axons without varicosities or blebbing and whose growth cones remained healthy for the duration of the experiment were evaluated. Phase-contrast images of the same growth cones were taken at 0 and 60 min. A growth cone was considered collapsed if it had less than two filopodia, each shorter than 10 mm 2 . Values are presented as per cent collapsed growth conesŝ .e.m. and P values were determined using the student t-test from experiments repeated a minimum of three times.
For measurement of rapamycin-resistant collapse, DIV2 DRGs were infected with IRES viruses and collapse assays were performed 48 h after infection. Boyden chambers 28 and RT-PCR 29 were prepared with modifications as described in Supplementary Fig. 3 . In situ hybridization. Antisense riboprobes were transcribed in vitro from sense oligonucleotides (see Supplementary Table) using MEGAscript (Ambion) with digoxigenin-conjugated UTP.
For fluorescent in situ hybridizations (FISH), DRGs were fixed overnight at 4 8C in 4% paraformaldehyde (PFA) in cytoskeleton buffer (CSB: 10 mM MES at pH 6.1, 138 mM KCl, 3 mM MgCl 2 , 2 mM EGTA and 0.4 M sucrose). Unless indicated, washes were performed in TBST (20 mM Tris at pH 8.0, 150 mM NaCl and 0.1% Triton X-100) for 3 £ 5 min. DRGs were permeabilized (0.5% Triton X-100 in TBS) for 10 min, then post-fixed (4% PFA in TBS) for 5 min, followed by acetylation (0.25% acetic anhydride in 0.1 M HEPES) for 10 min before equilibration with 4 £ sodium chloride-sodium citrate (SSC)/50% formamide for 20 min. For hybridization, coverslips were incubated with 15 ng riboprobes in 15 ml hybridization buffer (10% dextran sulphate, 4 £ SSC, 1 £ Denhardt's Solution, 40% formamide, 20 mM ribonucleoside vanadyl complex, 10 mM dithiothreitol, 1 mg ml 21 yeast tRNA and 1 mg ml 21 salmon sperm DNA) at 37 8C overnight. The coverslips were washed with 40% formamide/1 £ SSC at 37 8C for 20 min, three times each with 1 £ SSC and 0.1 £ SSC. DRGs were blocked (100 mM Tris-HCl at pH 8.0, 150 mM NaCl, 8% formamide, 5% BSA, 2.5% normal horse serum and 2.5% normal goat serum) for 30 min. Antidigoxin antibody (1:500, DI-22, Sigma) was pre-cleared with rat embryo powder for 2 h at 25 8C. Antibodies were as follows: GAP-43, GFAP, staufen (Chemicon); tau (Sigma); actin, RhoA (Santa Cruz Biotechnology). Secondary antibodies used were Alexa Fluor 488 and 546 (Molecular Probes). Image analysis and quantification of immunofluorescence. DRGs were fixed with 4% PFA in CSB overnight at 4 8C, permeabilized with 0.5% Triton X-100 in TBS, and blocked in 2% BSA in 20 mM Tris-HCl at pH 8.0 for 30 min. DRGs were labelled with anti-RhoA (26C4, 1:1,000). Similar results were obtained with a RhoA antibody against a separate epitope (sc-179, 1:1,000).
For image acquisition of RhoA mRNA (in situ hybridization), RhoA immunofluorescence or GAP-43 immunofluorescence, exposure times were kept constant and below grey scale saturation. Three-dimensional deconvolution was done with AutoDeblur (AutoQuant).
For RhoA immunofluorescence normalization, the signal in the GAP-43 immunofluorescence stack was thresholded and used to create a volume mask around fluorescent objects. This mask was then applied onto the RhoA Z series and the total pixel intensity within this volume was measured. The summed immunofluorescence intensity was normalized to the volume of the growth cone. Quantification of in situ hybridization was performed similarly, using the GAP-43 labelling to demarcate cellular boundaries.
For quantification of myr-dEGFP puncta a stack of images was threedimensionally deconvoluted. The stack of images was collapsed to a single image using the maximal projection. The fluorescence signal was thresholded, a top-hat filter was applied and regions around the fluorescent puncta were automatically traced. To exclude debris, a size exclusion limit was defined. The regions were transferred to the corresponding picture (0 or 60 min, respectively) and the average pixel intensities in the regions were plotted. Image analyses were performed with MetaMorph (Universal Imaging). Generation and infection of Sindbis virus. We used a Sindbis vector, pSinRep5, containing a point mutation in nsP2 (P726S) that reduces neuronal cytotoxicity 30 , and the helper plasmid DH-BB (S. Schlesinger, Washington University). The 3 0 nontranslated region (3 0 NTR) of pSinRep5 was replaced with 3 0 UTRs of interest, preserving the 29 nucleotide CSE required for replication and polyadenylation 15 . Pseudoviruses were prepared according to the manufacturer's instructions (Invitrogen), purified using a sucrose gradient, concentrated and titered using BHK-21 cells.
